YOUR BUSINESS AUTHORITY
Springfield, MO
The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the agency, stoking worries that the plan may run afoul of legal, ethical and scientific standards long used to vet the safety and effectiveness of new medicines.
At the highest levels of the FDA, questions remain about which officials have the legal authority to sign off on drugs cleared under the Commissioner’s National Priority Voucher program, which promises approval in as little as one month for medicines that support “U.S. national interests.”
Read more from the Associated Press.
Complete with a 45-foot pedestrian bridge, this project adds a 10-foot-wide walking trail in front of Nixa’s High Pointe Elementary School and Summit Intermediate School.
AI expert gives advice at SBJ's People You Need to Know
European-style Christmas market to make debut in Branson next week
Big Cedar Lodge golf courses place on Golfweek list
Original, historic Pipkin building up for sale
Pizza Hut co-founder Dan Carney dies
Annual downtown holiday events combine for Nov. 21 celebration